SABCS 2022 | Remaining questions regarding the use of adjuvant chemotherapy in breast cancer

Prashanth Ashok Kumar, MD, Upstate University Hospital, Syracuse, NY, discusses remaining questions regarding the use of adjuvant chemotherapy in breast cancer, including on the menopausal effect, ovarian suppression, direct cytotoxic effects that it causes, and whether chemotherapy has benefits compared to ovarian suppression in premenopausal patients. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) 2022 in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.